New Court Orders Issued After August Conference in Federal Mirena Lawsuit Litigation
Multiple court orders were issued in the federal Mirena lawsuit litigation shortly after its most recent status conference on August 14th, including one to establish a pretrial schedule for certain matters related to claims filed in the proceeding, and another to approve both Plaintiffs and Defense Fact Sheets.
According to recent documents, the order adopting a pretrial schedule will be dependent on completion of discovery and filing of opening dispositive motion papers on May 15, 2015. Both of which will affect more than 100 Mirena IUD lawsuit claims filed in the U.S. District Court, Southern District of New York, which allege complications stemming from spontaneous migration of the IUD. Mirena lawsuits have been filed throughout the U.S. by women who allegedly experienced organ damage, uterine perforations, infection, scarring, ectopic pregnancy and other complications, many of which requiring Mirena removal surgery to correct.
According to lawsuits, Bayer Healthcare Pharmaceuticals failed to warn doctors and patients about the potential for these complications to occur after implantation of the intrauterine birth control device. What’s more, the company has a long-standing history of overstating the efficiency of its product and downplaying the risks—in 2009, the U.S. Food and Drug Administration (FDA) issued a warning letter citing misleading claims in one of Bayer’s promotional campaigns for Mirena.
Over 180 Mirena Lawsuit Claims Filed in New Jersey Litigation
The next status conference in the federal Mirena litigation has been scheduled for September 26, 2013. Meanwhile, at least 180 IUD lawsuits have been filed in a consolidated proceeding underway in New Jersey’s Bergen County Superior Court. There, a conference has been set for September 25, 2013. (In Re: Mirena Litigation; Case No. 297)
It is estimated that the Mirena IUD is currently used by more than 2 million women in the U.S., after being approved in 2000 by the U.S. Food and Drug Administration (FDA).According to recent data from the agency, the device has been named in 70,000 adverse event reports since then, many of which involving uterine perforation stemming from spontaneous migration. This Mirena complication occurs when the IUD moves away from its original point of insertion in the uterus and into other organs.
Filing a Mirena Lawsuit
As the federal and state Mirena lawsuit litigations move forward, the time is now to file your claim against the manufacturer of this IUD. Contact the lawyers at Bernstein Liebhard LLP for a free and confidential case evaluation at (877) 779-1414.